Galen is a global pharmaceutical company selling medicines worldwide in the areas of pain management, dermatology and gastroenterology, and partners with like-minded companies to accomplish this.
Established in 1968, with headquarters in Craigavon, Northern Ireland, we work in partnership with healthcare professionals and patients to advance human health.
We actively seek new markets and new opportunities, toward fulfilling our vision of creating a truly international pharmaceutical company from our base in Northern Ireland.
See below for more on our business, our background and our values.
By combining innovation in product development with competitive pricing, Galen works in partnership with healthcare professionals and patients to create real, long-term value, a major factor in the company’s success to date.
Galen is a privately owned pharmaceutical company established in 1968, with headquarters in Craigavon, Northern Ireland.
Our expertise lies in
We market pharmaceuticals across the UK, Europe, the USA and the Nordics.
Through organic growth and acquisitions, Galen has established product sales in 23 countries.
With commercial operations based in the UK, Ireland, USA and the Nordics, Galen is also a lead member of Rx-Alliance, an international network of partners.
Galen is proud to be one of the Almac Group family of world-class companies in the pharmaceutical and biotech sectors. The Group is wholly owned by the McClay Foundation, whose overarching aim is to make a meaningful improvement and advancement in human health.
Galen was founded in Craigavon, Northern Ireland in 1968 by the late Sir Allen McClay (d. 2010), the revered philanthropist and entrepreneur.
Sir Allen invested his wealth in research and innovation, to ensure the latest advances in healthcare would be available to all, and to foster employment opportunities locally. In 1997, Galen became Northern Ireland’s first £1 billion company.
We champion the values upon which Galen was built, and remain passionate about Sir Allen’s mission to improve and optimise human health, and to achieve a meaningful impact on patients' lives.
Telephone: +353 42 932 0718
Telephone: +1(215) 660 8500
POA Pharma Scandinavia AB,
Ebbe Lieberathsgatan 21, Box 24026,
400 22 Gothenburg Sweden